Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

ClinicalTrials.gov ID: NCT01108510

Public ClinicalTrials.gov record NCT01108510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 4:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the safety and efficacy of a regimen containing cobicistat-boosted atazanavir (ATV+COBI) plus emtricitabine/tenofovir disoproxil fumarate (Truvada®; FTC/TDF) fixed-dose combination (FDC) versus ritonavir-boosted atazanavir (ATV+RTV) plus FTC/TDF FDC in HIV-1 infected, antiretroviral treatment-naive adults. Participants will be randomized in a 1:1 ratio. Randomization will be stratified by HIV-1 RNA level (≤ 100,000 copies/mL or \> 100,000 copies/mL) at screening.

Study identification

NCT ID
NCT01108510
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
698 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2010 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Apr 2015 (Actual)
Last update posted
May 23, 2016

2010 – 2015

United States locations

U.S. sites
64
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Spectrum Medical Group Phoenix Arizona 85012 —
Health for Life Clinic PLLC Little Rock Arkansas 72207 —
Living Hope Clinical Foundation Long Beach California 90813 —
Kaiser Permanente Los Angeles California 90027 —
Los Angeles Gay and Lesbian Center DBA Jeffrey Goodman Special Care Clinic Los Angeles California 90028 —
Peter J Ruane, MD, Inc Los Angeles California 90036 —
Oasis Clinic Los Angeles California 90059 —
Anthony Mills MD Inc Los Angeles California 90069 —
University of California, Davis Medical Center Sacramento California 95817 —
Kaiser Permanente Medical Group Sacramento California 95825 —
La Playa Medical Group and Clinical Research San Diego California 92103 —
Metropolis Medical San Francisco California 94115 —
Kaiser Permanente Medical Center, Clinical Trials Unit San Francisco California 94118 —
Apex Research, LLC Denver Colorado 80220 —
Dupont Circle Physicians Group Washington D.C. District of Columbia 20009 —
Whitman-Walker Clinic Washington D.C. District of Columbia 20009 —
George Washington University Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Therafirst Medical Center Fort Lauderdale Florida 33308 —
Broward Health/Comprehensive Care Center Fort Lauderdale Florida 33311 —
Midway Immunology and Research Center Ft. Pierce Florida 34982 —
The Kinder Medical Group Miami Florida 33133 —
University of Miami School of Medicine Miami Florida 33136 —
Wohlfeiler, Piperato and Associates, LLC Miami Beach Florida 33139 —
Orlando Immunology Center Orlando Florida 32803 —
Idocf/ Valuhealthmd, Llc Orlando Florida 32806 —
University of South Florida HIV Clinical Research Unit / Hillsborough County Health Department Tampa Florida 33602 —
Infectious Disease Research Institute Inc. Tampa Florida 33614 —
St. Joseph's Comprehensive Research Institute Tampa Florida 33615 —
Infectious Disease Specialists of Atlanta Decatur Georgia 30033 —
Mercer University School of Medicine Macon Georgia 31210 —
Howard Brown Health Center Chicago Illinois 60613 —
Johns Hopkins University School of Medicine Baltimore Maryland 21205 —
Community Research Initiative of New England Boston Massachusetts 02215 —
Be Well Medical Center Berkley Michigan 48072 —
Henry Ford Health System Detroit Michigan 48202 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
CentralWest Clinical Research St Louis Missouri 63108 —
Saint Michaels Medical Center Newark New Jersey 07102 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
SouthWest CARE Center Santa Fe New Mexico 87505 —
North Shore University Hospital Manhasset New York 11030 —
Chelsea Village Medical, PC New York New York 10011 —
Mt Sinai School of Medicine New York New York 10011 —
Ricky K. Hsu, MD, PC New York New York 10011 —
Montefiore Medical Center - AIDS Center The Bronx New York 10467 —
Carolinas Medical Center-Myers Park Charlotte North Carolina 28207 —
Duke University Medical Center Durham North Carolina 27710 —
East Carolina University, The Brody School of Medicine Greenville North Carolina 27834 —
Rosedale Infectious Diseases Huntersville North Carolina 28078 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Division of Infectious Diseases, Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Philadelphia FIGHT Philadelphia Pennsylvania 19107 —
University of South Carolina Columbia South Carolina 29203 —
Southwest Infectious Disease Clinical Research, Inc. Dallas Texas 75204 —
Tarrant County Infectious Disease Associates Fort Worth Texas 76104 —
Garcia's Family Health Group Harlingen Texas 78550 —
Therapeutic Concepts, PA Houston Texas 77004 —
Gordon E. Crofoot MD PA Houston Texas 77098 —
Research Access Network Houston Texas 77098 —
DCOL Center for Clinical Research Longview Texas 75605 —
Peter Shalit, M.D. Seattle Washington 98104 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01108510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01108510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →